T4624 |
PGD2-IN-1
|
885066-67-1
|
99.46%
|
|
PGD2-IN-1 (PGD2-inhibitor) is an effective DP receptor antagonist (IC50:0.3 nM), a compound that can inhibit prostaglandin D2 (PGD2) signaling. PGD2-IN-1 specifi...
|
T3306 |
PF-04418948
|
1078166-57-0
|
99.45%
|
|
PF-04418948 is a potent EP2 receptor antagonist (IC50 = 16 nM for human EP2 receptors). Displays over 2000-fold selectivity for EP2 receptors over EP1, EP3, EP4,...
|
T3889 |
Platycodin D
|
58479-68-8
|
99.43%
|
|
Platycodin D may stimulate TNF-α synthesis or inhibit degradation of TNF-α mRNA. Platycodin D (10/30 μM) suppresses prostaglandin E2 production in rat peritoneal...
|
TN1362 |
Afzelin
|
482-39-3
|
99.38%
|
|
Afzelin (Kaempferol-3-O-rhamnoside) has several cellular activities such as DNA-protective, antibacterial, antioxidant, and anti-inflammatory as well as UV-absor...
|
T4436 |
RO1138452
|
221529-58-4
|
99.34%
|
|
RO1138452 (CAY10441) is a selective and orally bioavailable antagonist of prostacyclin receptor (pKi: 8.3). It antagonizes the carbaprostacyclin-induced activati...
|
T62525 |
TP-16
|
2332972-26-4
|
99.33%
|
|
TP-16 is a novel potent and selective EP4 antagonist that blocks the function of IMCs and enhances cytotoxic T cell-mediated tumor elimination in vivo.
|
T3174 |
Taprenepag
|
752187-80-7
|
99.32%
|
|
Taprenepag (CP-544326) (CP-544326) is a potent and selective prostaglandin E2 receptor agonist (EC50 = 2.8 nM). Taprenepag has been used in trials studying the t...
|
T11340 |
Furprofen
|
66318-17-0
|
99.32%
|
|
Furprofen, a non-steroidal anti-inflammatory drug (NSAID), exerts its effects by inhibiting the synthesis of prostaglandin (PGE). This compound demonstrates anal...
|
T5386 |
Asapiprant
|
932372-01-5
|
99.23%
|
|
Asapiprant (S-555739) is a potent and selective DP1 receptor antagonist (Ki: 0.44 nM). It exhibited high affinity and selectivity for the DP1 receptor.
|
T3520 |
Setipiprant
|
866460-33-5
|
99.16%
|
|
Setipiprant (ACT-129968) is an orally available, selective CRTH2 antagonist (IC50: 6.0 nM). CRTH2 is a G protein-coupled receptor for prostaglandin (PGD2). PGD2 ...
|
TQ0203 |
Tafluprost
|
209860-87-7
|
99.16%
|
|
Tafluprost, a prostaglandin analog, is the selective agonist of fluoroprostaglandin (FP) receptor PGF2α.
|
T5482 |
TG4-155
|
1164462-05-8
|
99.14%
|
|
TG4-155 is a brain penetrant EP2 antagonist (KB = 2.4 nM) that is over 1000-fold less effective at EP4 (KB = 11.4 µM) and a panel of other receptors and channels...
|
TQ0025 |
E7046
|
1369489-71-3
|
99.09%
|
|
E7046 is a specific, orally bioavailable EP4 antagonist (IC50: 13.5 nM, Ki: 23.14 nM), exhibiting anti-tumor activities.
|
T12268 |
NTP42
|
2055599-51-2
|
99.09%
|
|
NTP42 is an antagonist of thromboxane A2 (TXA2) receptor(IC50 of 3.278 nM)
|
T1626 |
Prostaglandin E1
|
745-65-3
|
99.05%
|
|
Prostaglandin E1 (Alprostadil) is the naturally occurring prostaglandin E1 (PGE1) which displays a variety of pharmacologic actions. Prostaglandin E1 is a potent...
|
T2S0765 |
Epibetulinic acid
|
38736-77-5
|
99.02%
|
|
Epibetulinic acid has anti-inflammatory activity, it exhibits potent inhibitory effects on NO and prostaglandin E(2) production in mouse macrophages (RAW 264.7) ...
|
T3868 |
Agnuside
|
11027-63-7
|
98.98%
|
|
Agnuside (chasteberry oil) inhibits COX-2 (IC50: 0.026 mg/ml) but exhibits less than 10% inhibition of COX-1 at this concentration. It also inhibits 46.3, 66.8, ...
|
T8883 |
Pizuglanstat
|
1244967-98-3
|
98.96%
|
|
Pizuglanstat is a hematopoietic prostaglandin synthase inhibitor.
|
TN1134 |
Euscaphic acid
|
53155-25-2
|
98.93%
|
|
Euscaphic acid has anti-diabetic, and anti-inflammatory activities, it inhibits LPS-induced inflammatory responses by interference with the clustering of TRAF6 w...
|
T3903 |
Angoroside C
|
115909-22-3
|
98.92%
|
|
Angoroside C is a Potential anti-inflammatory compound. Inhibitor of prostaglandin E2 release in mouse peritoneal macrophages in vitro. Shows potent antioxidativ...
|